For Patients

Cancer

Cancer Moonshot

Cancer Moonshot: White House Task Force Reportdisclaimer icon

Recommendations describe how government, industry, research, institutions, and healthcare providers can work together to make progress against cancer.

We work with FDA's oncology (cancer) medical staff to bring your perspective into the review of new drugs to treat or prevent cancer. We also meet with organized patient advocacy groups to hear their concerns about drug development and to assist them in understanding the FDA drug regulatory process. 

You and your loved ones can contact the Office of Health and Constituent Affairs with questions about cancer clinical trials or cancer drug development.   

NCI and the Precision Medicine Initiative

The Precision Medicine Initiative® (PMI) is a $215 million investment in President Obama’s Fiscal Year 2016 Budget to accelerate biomedical research and provide clinicians with new tools to select the therapies that will work best in individual patients. The PMI’s $70 million in funding for NCI is being used to advance the field of precision oncology. Other disease areas will be included over the longer term.

Oncology is a natural choice as the initial focus for this ambitious initiative. Precision medicine uses the genetics of disease to identify effective therapies, and, thanks in large part to NCI-supported research, we know that cancer is a disease of the genome.

Oncology is already well along the path to precision medicine. NCI has launched a series of precision medicine clinical trials since 2014, many genetically targeted therapies are currently available to cancer patients, and many more are expected to become available in the near future. More information

Get email updates about drug approvals, drug safety and other issues related to oncology by subscribing to FDA's Office of Hematology and Oncology Products Email Updates.

Page Last Updated: 11/10/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English